Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Vaginal dryness

Aromatase inhibitors are relatively well tolerated however have a number of distinct side effects are observed that stem from the state of estrogen deprivation induced by aromatase inhibitors. Side effects include hot flashes, joint and muscle aches, vasomotor symptoms and vaginal dryness. Variable effects of aromatase inhibitors on lipid levels have been observed. Trials comparing third generation aromatase inhibitors to tamoxifen have also repotted an increased risk of cardiovascular events in the group receiving aromatase inhibitors. [Pg.221]

Phosphodiesterase 5 inhibitors such as sildenafil are effective for MS-induced erectile dysfunction.14 In women, vaginal dryness or dyspareunia may respond to lubricating jellies. [Pg.440]

Possible complaints of infertility, vaginal dryness, decreased libido... [Pg.753]

If treatment with an SSRI or another antidepressant such as clomipramine is not successful, hormonal treatment with a GnRH agonist, such as leuprolide, maybe considered. The use of leuprolide improves premenstrual emotional symptoms as well as some physical symptoms such as bloating and breast tenderness. Cost, the need for intramuscular administration, and the side effects of hypoestrogenism (e.g., vaginal dryness and hot flashes) limit its use. [Pg.762]

O Common symptoms of menopause include hot flashes, night sweats, vulvovaginal atrophy, and vaginal dryness. Women less commonly may experience mood swings, depression, insomnia, arthralgia, myalgia, and urinary frequency. [Pg.765]

BW, a 50-year-old woman with a history of osteoarthritis and hypothyroidism, presents to the clinic complaining of hot flashes, vaginal dryness, and insomnia. She states that she experiences approximately two hot flashes per day and is awakened from sleep at least three to four times a week in a "pool of sweat" requiring her to change her clothes and bed linens. Her symptoms began about 3 months ago, and over that time, they have worsened to the point where they have become very bothersome. On questioning, she states her last menstrual period was 1 year ago. [Pg.766]

Dyspareunia may result from vaginal dryness. Water-based lubricants may provide relief for several hours after application. Moisturizers may provide relief for a longer period of time and potentially can prevent infections by maintaining the acidic environment in the vagina. Both these treatments require frequent application. [Pg.768]

Based on the information presented, create a care plan for BW s hot flashes and vaginal dryness. The plan should include (1) a statement identifying the patient problem and its severity, (2) goals of therapy, (3) a therapeutic plan based on individual patient-specific factors, (4) subjective and objective monitoring parameters, and (5) a follow-up evaluation to assess for adverse effects and adherence and to determine if the goals of therapy have been achieved. [Pg.776]

Monitor the patient for a reduction in vasomotor symptoms, vaginal dryness, and improvement in sleep. Also monitor for breakthrough bleeding and spotting, adverse effects of HRT, and improvement in QOL. [Pg.776]

Other symptoms include vaginal dryness, dyspareunia, urogenital atrophy, sleep disturbances, sexual dysfunction, and impaired concentration and memory. [Pg.354]

Mild vaginal dryness can sometimes be relieved by nonestrogenic vaginal creams, but significant vaginal dryness often requires local or systemic estrogen therapy. [Pg.355]

Options for adjuvant hormonal therapy in postmenopausal women include aromatase inhibitors (e.g. anastrozole, letrozole, or exemestane) either in place of or after tamoxifen. Adverse effects with aromatase inhibitors include hot flashes, myalgia/arthralgia, vaginal dryness/atrophy, mild headaches, and diarrhea. [Pg.698]

Local treatment should be offered to all women, especially those not receiving hormone treatment. Urogenital atrophy and vaginal dryness is frequent, but women have difficulties in expressing these symptoms, which is why the clinician should address this issue systematically. [Pg.352]

Adverse effects include flushes, weight gain, mood changes, vaginal dryness, decreased libido, breast enlargement and tenderness and in some patients the prolonged time required for the return of normal ovulatory function. Androgen side-effects like acne and hirsutismus can occur with the 19-nortestosterone derivatives. [Pg.402]

Tamoxifen administration is associated with few toxic side effects, most frequently hot flashes (in 10-20% of patients) and occasionally vaginal dryness or discharge. Mild nausea, exacerbation of bone pain, and hypercalcemia may occur. [Pg.650]

Adverse effects include hot flushes, change in libido, vaginal dryness, headache. Incidents of emotional lability and depression are higher in infertile patients. [Pg.273]

Tamoxifen can cause loss of libido (63). In 57 patients sexual desire, arousal, and the ability to achieve orgasm were unaffected by tamoxifen (64). There was a 54% incidence of dyspareunia, but this seemed to be a consequence of co-administration of chemotherapy, which can cause vaginal dryness and loss of libido, rather than an effect of tamoxifen. [Pg.306]

Other climacteric symptoms include disturbances in the menstrual pattern, palpitation, headache, dizziness, numbness, myalgia, vaginal dryness and urinal tract symptoms. In over half of the climacterically symptomatic women also mental symptoms, such as anxiety, depression, decline in libido, lack of concentration, and memory impairment, are present these can exceed the severity of vasomotor symptoms. Further, sleeping problems are frequent during menopausal transition. They may show as exclusive symptoms or in addition to other climacteric symptoms. They are often attributed to nocturnal vasomotor symptoms. In menopausal women vasomotor symptoms are reported in 65-85 %, mental symptoms in 50-80 % and sleeping problems in 50-80% [23, 24], The duration of the symptoms has a wide variety. Vasomotor symptoms are experienced for 1-2 years in most of the women, but about 25 % will experience them for 5 years and even 9 % practically all lifelong [25, 26]. [Pg.184]

Menopause - hot flushes, night sweats, sleep disturbance, vaginal dryness and discomfort. [Pg.144]

Other adverse effects of GnRh analogues include insomnia, reduced libido, vaginal dryness and headaches. [Pg.167]


See other pages where Vaginal dryness is mentioned: [Pg.142]    [Pg.767]    [Pg.767]    [Pg.768]    [Pg.770]    [Pg.776]    [Pg.362]    [Pg.68]    [Pg.303]    [Pg.322]    [Pg.331]    [Pg.344]    [Pg.149]    [Pg.354]    [Pg.769]    [Pg.799]    [Pg.840]    [Pg.894]    [Pg.127]    [Pg.488]    [Pg.653]    [Pg.427]    [Pg.428]    [Pg.279]    [Pg.867]    [Pg.85]    [Pg.129]    [Pg.301]    [Pg.274]    [Pg.288]   
See also in sourсe #XX -- [ Pg.323 , Pg.336 , Pg.344 ]




SEARCH



Dryness

Vaginal

Vaginitis

© 2024 chempedia.info